Silo Pharma, Inc. (SILO) stock
SILONasdaqPharmaceutical PreparationsFiscal year ends December 31
$1.71+0.14 (+8.57%)
Close on Nov 17, 2026Market cap $2.72MP/E –Yield –
Silo Pharma operating cash flow
Operating cash flow is the cash the business generates from its day-to-day operations.
Silo Pharma's operating cash flow for the twelve months ending Jun 30, 2026 was -$3.34M. For fiscal 2025 it was -$4.66M. The highest annual figure on record is $272.64K in fiscal 2018.
Annual operating cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$4.66M | – |
| FY2024 | Dec 31, 2024 | -$3.83M | – |
| FY2023 | Dec 31, 2023 | -$3.22M | – |
| FY2022 | Dec 31, 2022 | -$3.50M | – |
| FY2021 | Dec 31, 2021 | -$2.28M | – |
| FY2020 | Dec 31, 2020 | -$1.16M | – |
| FY2019 | Dec 31, 2019 | -$794.32K | -391.3% |
| FY2018 | Dec 31, 2018 | $272.64K | – |
| FY2017 | Dec 31, 2017 | -$284.62K | – |
| FY2013 | Dec 31, 2013 | -$181.61K | – |
| FY2012 | Dec 31, 2012 | -$21.47K | – |
| FY2011 | Dec 31, 2011 | -$46.30K | – |
Quarterly operating cash flow
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -$781.86K | – |
| Q1 FY2026 | Mar 31, 2026 | -$822.62K | – |
| Q4 FY2025 | Dec 31, 2025 | -$780.28K | – |
| Q3 FY2025 | Sep 30, 2025 | -$955.49K | – |
| Q2 FY2025 | Jun 30, 2025 | -$1.29M | – |
| Q1 FY2025 | Mar 31, 2025 | -$1.64M | – |
| Q4 FY2024 | Dec 31, 2024 | -$917.43K | – |
| Q3 FY2024 | Sep 30, 2024 | -$1.35M | – |
| Q4 FY2023 | Dec 31, 2023 | -$910.01K | – |
| Q1 FY2023 | Jun 30, 2023 | -$1.24M | – |
| Q4 FY2022 | Dec 31, 2022 | -$885.99K | – |
| Q3 FY2022 | Sep 30, 2022 | -$1.42M | – |
| Q2 FY2022 | Jun 30, 2022 | -$400.11K | – |
| Q1 FY2022 | Mar 31, 2022 | -$789.17K | – |
| Q4 FY2021 | Dec 31, 2021 | -$773.87K | – |
| Q3 FY2021 | Sep 30, 2021 | -$663.08K | – |
| Q2 FY2021 | Jun 30, 2021 | -$521.75K | – |
| Q1 FY2021 | Mar 31, 2021 | -$319.32K | – |
| Q4 FY2020 | Dec 31, 2020 | -$536.32K | – |
| Q3 FY2020 | Sep 30, 2020 | -$280.62K | – |
| Q2 FY2020 | Jun 30, 2020 | -$222.45K | – |
| Q1 FY2020 | Mar 31, 2020 | -$117.61K | – |
| Q4 FY2019 | Dec 31, 2019 | -$292.80K | – |
| Q3 FY2019 | Sep 30, 2019 | -$200.09K | – |
| Q2 FY2019 | Jun 30, 2019 | -$151.90K | -152.4% |
| Q1 FY2019 | Mar 31, 2019 | -$149.52K | -178.0% |
| Q4 FY2018 | Dec 31, 2018 | -$158.89K | – |
| Q3 FY2018 | Sep 30, 2018 | -$50.09K | – |
| Q2 FY2018 | Jun 30, 2018 | $289.94K | – |
| Q1 FY2018 | Mar 31, 2018 | $191.68K | – |
| Q4 FY2017 | Dec 31, 2017 | -$7.10K | – |
| Q2 FY2013 | Jun 30, 2013 | -$41.41K | – |
| Q1 FY2013 | Mar 31, 2013 | -$10.18K | – |
| Q4 FY2012 | Dec 31, 2012 | -$5.00K | – |
| Q3 FY2012 | Sep 30, 2012 | -$534 | – |
See a number that looks wrong?